News - Greater Bay Area International Clinical Trial Institute

19.08.2025

GBAICTI Showcased Hong Kong's Clinical Trial Strengths to Visiting Greater Bay Area Biomedical Delegation

GBAICTI presented Hong Kong's unique clinical trial advantages to a delegation of over 30 biomedical enterprise representatives from the Greater Bay Area, fostering cross-border collaboration in medical innovation.

12.08.2025

HKUMed, SMART and GBAICTI Met in Hong Kong to Foster Talent Exchange and Collaboration

On August 12, 2025, Prof. Bernard Cheung, CEO of GBAICTI, and Prof. CS Lau, Dean of HKUMed, met in Hong Kong with Prof. Nieng Yan, Founding President of Shenzhen Medical Academy of Research and Translation (SMART).

31.07.2025

GBAICTI Engaged With About 100 Industry Representatives to Enhance Hong Kong's Clinical Research Development

At a sharing session hosted by the Hospital Authority, the Greater Bay Area International Clinical Trial Institute (GBAICTI) engaged in-depth with around 100 industry representatives from over 30 companies to discuss enhancement measures and the future development of clinical trials in Hong Kong.

29.07.2025

GBAICTI, Bay Trial and Immuno Cure Signed Tripartite MOU to Strengthen GBA Clinical Research Collaboration

Greater Bay Area International Clinical Trial Institute, Greater Bay Area International Clinical Trials Center of Shenzhen and Immuno Cure BioTech signed a tripartite Memorandum of Understanding on July 29, 2025.

29.07.2025

GBAICTI and Bay Trial Signed a MOU to Strengthen Clinical Research Collaboration

GBAICTI and Bay Trial signed a Memorandum of Understanding on July 29, 2025 to strengthen collaboration between Shenzhen and Hong Kong in the field of clinical research.

09.07.2025

GBAICTI and Hong Kong Genome Institute Explore Partnership in Genomic Medicine

Greater Bay Area International Clinical Trial Institute (GBAICTI) met with Hong Kong Genome Institute (HKGI) to explore collaborative opportunities in genomic medicine.